Kassif Lerner, R.; Stein Yeshurun, M.; Hemi, R.; Zada, N.; Asraf, K.; Doolman, R.; Benoit, S.W.; Santos de Oliveira, M.H.; Lippi, G.; Henry, B.M.;
et al. The Predictive Value of Serum ACE2 and TMPRSS2 Concentrations in Patients with COVID-19—A Prospective Pilot Study. J. Pers. Med. 2022, 12, 622.
https://doi.org/10.3390/jpm12040622
AMA Style
Kassif Lerner R, Stein Yeshurun M, Hemi R, Zada N, Asraf K, Doolman R, Benoit SW, Santos de Oliveira MH, Lippi G, Henry BM,
et al. The Predictive Value of Serum ACE2 and TMPRSS2 Concentrations in Patients with COVID-19—A Prospective Pilot Study. Journal of Personalized Medicine. 2022; 12(4):622.
https://doi.org/10.3390/jpm12040622
Chicago/Turabian Style
Kassif Lerner, Reut, Michal Stein Yeshurun, Rina Hemi, Nahid Zada, Keren Asraf, Ram Doolman, Stefanie W. Benoit, Maria Helena Santos de Oliveira, Giuseppe Lippi, Brandon Michael Henry,
and et al. 2022. "The Predictive Value of Serum ACE2 and TMPRSS2 Concentrations in Patients with COVID-19—A Prospective Pilot Study" Journal of Personalized Medicine 12, no. 4: 622.
https://doi.org/10.3390/jpm12040622
APA Style
Kassif Lerner, R., Stein Yeshurun, M., Hemi, R., Zada, N., Asraf, K., Doolman, R., Benoit, S. W., Santos de Oliveira, M. H., Lippi, G., Henry, B. M., Pessach, I. M., & Pode Shakked, N.
(2022). The Predictive Value of Serum ACE2 and TMPRSS2 Concentrations in Patients with COVID-19—A Prospective Pilot Study. Journal of Personalized Medicine, 12(4), 622.
https://doi.org/10.3390/jpm12040622
